Literature DB >> 16284024

Competition and new technology.

Mark V Pauly1.   

Abstract

Most real medical spending growth is accounted for by beneficial but costly new technology. This paper argues that a missing dimension of our concepts of competition among health plans is a focus on their policy toward new technology. In principle, plans could choose to move rapidly or slowly, inclusively or selectively, toward adopting new technologies, broadly defined. These policies would affect the rates of growth of their premiums, and consumers could choose among plans depending on both the technology policy and premium growth. Legal impediments, physician resistance, and membership turnover are all possible obstacles. Further thought should be given to making technology policy an explicit dimension of plan competition.

Mesh:

Year:  2005        PMID: 16284024     DOI: 10.1377/hlthaff.24.6.1523

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  Wussinomics: the state of competitive efficiency in private health insurance.

Authors:  Mark Pauly
Journal:  Int J Health Care Finance Econ       Date:  2012-08-28

2.  Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment.

Authors:  Nikhil G Thaker; Ankit Agarwal; Matthew Palmer; Rosemarie Hontiveros; Stephen M Hahn; Bruce D Minsky; Ronald Walters; John Bingham; Thomas W Feeley; Thomas A Buchholz; Steven J Frank
Journal:  Int J Part Ther       Date:  2016-03-24

3.  Polity and health care expenditures: the association among 159 nations.

Authors:  Leah E Gregorio; David I Gregorio
Journal:  J Epidemiol Glob Health       Date:  2013-02-04

4.  Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer.

Authors:  Nikhil G Thaker; David Boyce-Fappiano; Matthew S Ning; Dario Pasalic; Alexis Guzman; Grace Smith; Emma B Holliday; James Incalcaterra; Adam S Garden; Simona F Shaitelman; G Brandon Gunn; C David Fuller; Pierre Blanchard; Thomas W Feeley; Robert S Kaplan; Steven J Frank
Journal:  Int J Part Ther       Date:  2021-06-25

5.  Limited use of price and quality advertising among American hospitals.

Authors:  David B Muhlestein; Chrisanne E A Wilks; Jason P Richter
Journal:  J Med Internet Res       Date:  2013-08-29       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.